From the Departments of Anesthesiology (U.B., H.L., M.D.) and Surgery
(W.L.), Division of Vascular Surgery, University of Erlangen-Nuremberg,
Erlangen, FRG.
Correspondence to Ulrich Beese, MD, Department of Anesthesiology, Krankenhausstr 12, 91054 Erlangen, Germany. E-mail beese{at}anaesthesiologie.med.uni-erlangen.de
MethodsIn 317 patients undergoing reconstructive surgery on the
internal carotid artery, simultaneous recordings of
SEP and rSO2 were obtained throughout the
operation.
ResultsAll 287 patients with preserved cortical SEP remained
neurologically intact. Shunt placement was performed in 27 patients
(9%) after flattening of cortical SEP during cross-clamping of the
internal carotid artery. A stable rSO2 value
just before cross-clamping and the lowest value after cross-clamping
were registered, and the decrease was calculated. A statistically
significant (P<0.01) decrease of
rSO2 after cross-clamping could be found in
patients without (64.9±8.3% to 60.9±9.9%) as well as in patients
with consecutive loss of cortical SEP (65.8±9.1% to
56.1±13.4%). The difference of the decrease of
rSO2 in both groups was highly significant
(6.9±9.0% versus 15.6±14.0%; P<0.001). However,
substantial interindividual variability of rSO2
and derived change of rSO2 did not allow the
definition of a threshold value indicating need of shunt placement.
ConclusionsThe reliability of SEP for the detection of
clamp-related hypoperfusion has been reaffirmed. As long as
rSO2 threshold values indicating critical
cerebral ischemia are not defined, therapeutic interventions
based on monitoring with the cerebral oximeter INVOS 3100A are not
justified.
The use of electroencephalography, somatosensory evoked potentials
(SEP), and transcranial Doppler sonography are
established forms of neuromonitoring in patients undergoing carotid
surgery.6 However, technical expertise and
experience in interpreting the results of these monitors are
necessary.
Cerebral oximetry appears to be an attractive alternative because it
relies on a continuous, noninvasive measurement principle and is easy
to use. Previous studies provided evidence that changes in cerebral
oxygenation caused by cross-clamping of the ICA can be
monitored by means of near-infrared spectroscopy
(NIRS).7 8 9 10 Since no "gold standard" with
which to test the sensitivity and specificity of cerebral oximetry
exists, the results of NIRS need to be compared with other validated
forms of neuromonitoring.11 A loss of cortical
SEP is a good indicator of cerebral hypoperfusion and is able to
identify patients at risk for intraoperative
stroke.12 13 14 However, given the relatively low
incidence of clamp-related ischemia in carotid surgery, it is
obvious that a large number of patients must be studied to obtain
sufficient data from patients developing severe cerebral
ischemia.15 This could not be
accomplished by previously published studies.
After validating the results of SEP with the individual neurological
outcome of the patients, we compared the changes of cortical SEP and
regional cerebral saturation (rSO2),
obtained by the cerebral oximeter INVOS 3100A, during cross-clamping of
the ICA. The intention of the present study was to determine
whether NIRS is able to detect severe cerebral ischemia
indicated by a loss of cortical evoked potentials and to evaluate the
clinical usefulness of the cerebral oximeter INVOS 3100A for the
management of the individual patient undergoing carotid surgery.
Patients with known arterial hypertension or
coronary artery disease were instructed to take their usual
antihypertensive or antianginal medications until the day of the
operation. A standard balanced anesthetic technique was used in all
patients. Anesthesia was induced with midazolam (0.03 to
0.05 mg/kg IV), fentanyl (2 to 3 µg/kg IV), etomidate (0.2 mg/kg IV),
vecuronium (0.1 mg/kg IV), or rocuronium (0.6 mg/kg IV) and maintained
by administration of repeated boluses of fentanyl (1 to 2 µg/kg IV),
vecuronium/rocuronium, and 0.4% to 1.0% inspired isoflurane. All
patients were artificially ventilated with 40% oxygen in nitrous
oxide. Analysis of intermittent drawn arterial
blood gas samples ensured normoventilation (4.7 to 5.2 kPa). Routine
monitoring during anesthesia included standard ECG (lead
II, V5), intra-arterial catheter for
direct arterial blood pressure measurement, pulse oximetry,
and capnography. Blood pressure was kept stable in a range of ±20% of
the preoperative level throughout the procedure by adjusting the depth
of anesthesia or, if needed, by intravenous
administration of a vasodilative (nitroglycerin) or a
vasoconstrictive (theoadrenaline) agent.
SEP were recorded from induction to reversal of
anesthesia by means of the Nicolet Pathfinder I
electrodiagnostic system (Nicolet Biomedical Co).
Detailed stimulation and recording parameters are
listed in Table 2
The cerebral oximeter INVOS 3100A (Somanetics) was used to measure
rSO2 throughout the procedure. After
the patient's skin was thoroughly cleaned, the sensor was placed
according to the manufacturer's instructions over the ipsilateral
forehead. The light transmitters were
All patients were extubated in the operation theater. At this point
patients were tested for the development of any new neurological
deficit. Patients were followed until the time of discharge from the
hospital.
Mean±SD values are expressed. The Wilcoxon test was used to
compare rSO2 values before and after
cross-clamping of the ICA. Comparisons of
rSO2 values before and after
cross-clamping as well as the calculated change of
rSO2 between patients with preserved
cortical SEP and SEP loss were performed with the Mann-Whitney
U test. All P values were 2-sided, and
significance was assessed at the 0.05 level. A commercially available
statistical package, SPSS for Windows, version 6.1 (SPSS Inc) was used
for performing the statistical analysis.
Continuous recording of SEP and
rSO2 was possible in all patients.
All 287 patients (90.5%) with preserved cortical SEP remained
neurologically intact after surgery. In 30 patients (9.5%), an SEP
loss with unaffected cervical components occurred during the clamping
phase. In 27 of these patients shunt placement was performed. Cortical
SEP recovered after shunt placement in all patients. Three patients
were not shunted despite a loss of SEP. The reasons were hypoplastic
vessel (1 case) or SEP loss in the late clamping phase and impairment
of arteriotomy closure (2 cases). In 1 of these patients cortical SEP
was restored by carotid declamping within 6 minutes; the patient
remained neurologically intact. The other 2 patients and 4 patients who
received an intraluminal shunt during cross-clamping of the ICA awoke
with a new neurological deficit on the side of the
endarterectomy. That deficit resolved completely
within 12 hours in all patients.
Corresponding preclamp and postclamp
rSO2 values, as well as the
calculated change of rSO2
(
As the accuracy parameters in Table 4
The purpose of our investigation was to determine whether NIRS by means
of the cerebral oximeter INVOS 3100A is capable of identifying patients
with restricted cerebral collateralization and resulting severe
cerebral ischemia, as indicated by a loss of cortical SEP. A
similar study was recently published by Duffy and
coworkers.20 In contrast to their study, in which
they used an arbitrary threshold value of
rSO2 decrease of >10% for
comparison with SEP, it was our intention to determine a threshold
value for rSO2 under which SEP loss
occurred and neuronal damage was likely to develop. This should answer
the question of whether NIRS can replace SEP, which is more technically
demanding.4
The results of our study confirmed that SEP monitoring reliably
identifies patients with impending cerebral damage, since all patients
with preserved cortical SEP remained neurologically intact. In 30
patients (9.5%), a loss of cortical evoked potentials was found after
cross-clamping of the ICA. Six patients (1.8%) awoke with a new
neurological deficit, which was transient in all cases.
Previous studies had demonstrated that absolute numbers of
rSO2 are of little value in
interpreting results obtained by means of INVOS
3100A.7 9 10 21 22 23 24 25 26 27 28 29 30 That is why the definition of
"normal values" for rSO2 is
highly questionable.
Misra and collegues28 recently reported wide
scattering of rSO2 values obtained by
normal subjects. Using the same kind of cerebral oximeter, Samra et
al9 found a similar high variability in awake
patients undergoing carotid endarterectomy under
regional anesthesia. They noted that a wide range of
rSO2 values are obviously unrelated
to neurological dysfunction. The results of our study confirmed the
variability of this parameter. Accordingly, we focused our
interest on the individual change of
rSO22. For the calculation we used a
stable value just before cross-clamping of the ICA and the lowest
stable value after cross-clamping. The use of a stable value after
cross-clamping should ensure that autoregulative changes were taken
into account, increasing the specificity of the derived threshold
value. Two minutes were allowed for stabilization because results by
Lam and coworkers31 suggest that autoregulation
after cross-clamping usually occurs within 1 minute. Since the blood
pressure was kept stable throughout the procedure, the displayed
rSO2 values could be expected to
reflect the changed oxygen balance of cerebral tissue after application
of the cross-clamp.
On average, rSO2 values in patients
with SEP loss after carotid cross-clamping were lower than in patients
with preserved cortical SEP. In turn, the calculated decrease of
rSO2 was significantly higher in
patients with SEP loss. However, no calculated value would reliably
identify patients with SEP loss who will benefit from shunt placement
with high sensitivity and acceptable specificity and predictive power.
Given a residual error of the displayed readings of
±10%,28 an arbitrary threshold value of >10%
decrease of rSO2, as done by Duffy et
al,20 is not appropriate. Therefore, selective
use of an intraluminal shunt based exclusively on the results of NIRS
cannot be recommended.
Whether a reduction of interindividual variability can be achieved is
uncertain for various reasons. As suggested by Kurth and
Uher,32 this variability originates in the
continuous-wave NIRS technology, since there is no way to measure
optical path length and absorption. Therefore, the algorithm for
calculation of rSO2 is based on
several assumptions, which may lead to an oversimplification of that
very complex issue.11 30 31 Anatomic variations
leading to differences of extracranial layers of scalp, skull, and
cerebrospinal fluid need to be considered as well as changes resulting
from biological variations in cerebral hemoglobin
concentration.27 29 30 The estimated proportions
of blood in the venous, arterial, and capillary
compartments are assumed to be stable. However, the fulfillment of this
condition in a clinical situation is difficult to
verify.24 30 A sudden decrease of cerebral blood
flow during cross-clamping of the ICA under general
anesthesia is possibly the closest
approximation.16 If variability of
rSO2 values unrelated to neurological
function occurs under these circumstances, the usefulness of this
device in more complex clinical situations such as intensive care
patients or patients undergoing cardiac surgery must be
questioned.33
Since early concerns were raised by Harris and
Bailey34 in 1993, the issue of extracranial
contamination of the derived signal has been a matter of considerable
debate. Based on experimental studies on artificial models, there is
evidence that changing emitter-detector separation will cause
differential spatial resolution.35 The fixed
interoptode spacing of 3 and 4 cm in the INVOS 3100A sensor is supposed
to ensure that by subtracting the signals from superficial layers,
extracranial contamination can be effectively
reduced.10 This assumption has been challenged by
various authors.27 36 Obviously, the fixed
interoptode spacing of the sensors will lead to differences in the
effectiveness of reducing extracranial contamination due to differences
in the anatomy of the patient's
skull.30 31 In contrast to other applications,
carotid surgery provides the unique opportunity of selectively clamping
the external carotid artery, thereby greatly reducing the influence of
extracranial tissue. Studies in which sequential clamping of the
external carotid artery before the ICA was performed provided
contradictory results. Duncan and colleagues7
found a nonsignificant fall of the displayed
rSO2 after clamping of the ECA. Using
a different type of cerebral oximeter (NIRO-500, Hamamatsu), Lam and
coworkers31 showed that the contribution of
extracranial vascular circulation to the results of NIRS was
significant. In contrast to the study by Duncan, parallel monitoring of
superficial blood flow by means of laser-Doppler flowmetry
was used. This offers the advantage of controlling extracranial
contamination, making collateral flow from the contralateral side
detectable. Furthermore, this monitor will track blood pressure
fluctuations that predominantly influence in a pressure-passive fashion
the extracranial vascular territory and are a significant source of
artifact. We believe that in future investigations efforts should be
made to adopt this proceeding and not to rely on spatial resolution
claimed for the Soma-Sensor used in the INVOS 3100A. The importance of
extracranial contamination was highlighted in a recently published
study by Kirckpatrick et al.37 Using the same
device as in the study by Lam, the authors were able to identify all
patients with severe cerebral ischemia, as indicated by a fall
of MCA velocity >60% or sustained fall in cortical electric activity
by means of a derived parameter of NIRS. However, this
threshold was only apparent when extracranial contamination was reduced
by previous clamping of the ECA. In our study we did not try to resolve
the extracranial and intracranial vascular territories by sequential
clamping of the carotid arteries. Therefore, it is possible that the
displayed rSO2 values are heavily
influenced by extracranial contamination. However, the results of our
study showed that severe cerebral ischemia, as indicated by
cortical SEP loss, occurred in some patients with minimal or even no
change of the displayed regional cerebral oxygenation.
Removal of extracranial contamination will probably increase
specificity of derived threshold values, indicating need for
intervention. However, most important for the outcome of the patients
and the value of the monitoring device is prompt recognition of all
patients with impending cerebral ischemia.
The discrepancy between cortical SEP loss and no or minimal change of
rSO2 after carotid cross-clamping
might be attributed to the different monitoring areas. Given the low
spatial resolution of the measurement
system,23 26 placement over the parietal middle
cerebral artery territory, as advocated by Williams and
coworkers,10 22 might lead to a better agreement
between SEP monitoring and NIRS.19 However, this
approach is hampered by the necessity of shaving an area of the
patient's head the size of the sensor pad (3.5x1.75 inches), which
will probably not be acceptable to many of the patients undergoing the
procedure for investigational purposes. The possibility of placing the
sensor over other parts of the skull without having to shave them first
needs to be addressed by the manufacturers. Interestingly, the
threshold values indicating severe cerebral ischemia in the
study by Kirckpatrick et al37 could be
defined with sensors placed over the patient's forehead, the same
area as recommended for the Soma-Sensor INVOS
system.38
Further studies are needed to evaluate the importance of probe
positioning for the sensitivity and specificity of NIRS. As suggested
by previous studies and our own clinical experience, NIRS appears to
work extremely well in some cases.7 9 19 As shown
in Figure 2
The advantage of NIRS is that it is easy to use and that it offers a
real-time and noninvasive means for the assessment of cerebral
oxygenation. Unfortunately, these advantages cannot
outweigh the represented methodological problems in the
cerebral oximeter INVOS 3100A. Since our study and previous
investigations9 were unable to define a threshold
value indicating severe cerebral ischemia in individual
patients, we would not advise therapeutic interventions based on
obtained
rSO225 26 27 30 and
would suggest not using this instrument for detection of cerebral
ischemia in patients undergoing carotid
endarterectomy under general
anesthesia.
Received May 26, 1998;
revision received July 8, 1998;
accepted July 8, 1998.
2.
Sorteberg A, Sorteberg W, Bakke SJ, Lindegaard KF,
Boysen M, Nornes H. Cerebral hemodynamics in internal
carotid trial occlusion. Acta Neurochir (Wien). 1997;139:10661073.[Medline]
[Order article via Infotrieve]
3.
McKinsey JF, Desai TR, Bassiouny HS, Piano G, Spire
JP, Zarins CK, Gewertz BL. Mechanisms of neurological deficits and
mortality with carotid endarterectomy. Arch
Surg. 1996;131:526531.
4.
Loftus CM, Quest DO. Technical issues in carotid
artery surgery 1995. Neurosurgery. 1995;36:629647.[Medline]
[Order article via Infotrieve]
5.
Spencer M. Transcranial Doppler
monitoring and causes of stroke from carotid
endarterectomy. Stroke. 1997;28:685691.
6.
Cheng MA, Theard MA, Tempelhoff R.
Anesthesia for carotid endarterectomy:
a survey. J Neurosurg Anesthesiol. 1997;9:211216.[Medline]
[Order article via Infotrieve]
7.
Duncan LA, Ruckley CV, Wildsmith JAW. Cerebral
oximetry: a useful monitor during carotid artery surgery.
Anesthesia. 1995;50:10411045.[Medline]
[Order article via Infotrieve]
8.
Kirckpatrick PJ, Smielewski P, Whitfield PC, Czosnyka
M, Menon D, Pickard JD. An observational study of near-infrared
spectroscopy during carotid endarterectomy.
J Neurosurg. 1995;82:756763.[Medline]
[Order article via Infotrieve]
9.
Samra SK, Dorje P, Zelenock GB, Stanley JC. Cerebral
oximetry in patients undergoing carotid
endarterectomy under regional
anesthesia. Stroke. 1996;27:4955.
10.
Williams IM, Picton A, Farrell A, Mead GE, Mortimer AJ,
Mc Collum CN. Light-reflective cerebral oximetry and jugular bulb
venous oxygen saturation during carotid
endarterectomy. Br J Surg. 1994;81:12911295.[Medline]
[Order article via Infotrieve]
11.
Wahr JA, Tremper KK, Samra S, Delpy DT. Near-infrared
spectroscopy: theory and applications. J Cardiothorac Vasc
Anesthesiol. 1996;10:406418.[Medline]
[Order article via Infotrieve]
12.
Prokop A, Meyer GP, Walter M, Erasmi H. Validity of SEP
monitoring in carotid surgery: review and own results. J
Cardiovasc Surg. 1996;37:337342.[Medline]
[Order article via Infotrieve]
13.
Schwartz ML, Panetta TF, Kaplan BJ, Legatt AD, Suggs
WD, Wengerter KR, Marin ML, Veith FJ. Somatosensory evoked potential
monitoring during carotid surgery. Cardiovasc Surg. 1996;4:7780.[Medline]
[Order article via Infotrieve]
14.
Dinkel M, Schweiger H, Goerlitz P. Monitoring during
carotid surgery: somatosensory evoked potentials vs. carotid stump
pressure. J Neurosurg Anesthesiol. 1992;4:167175.[Medline]
[Order article via Infotrieve]
15.
Fiori L, Parenti G, Marconi F. Combined
transcranial Doppler and electrophysiologic monitoring
for carotid endarterectomy. J Neurosurg
Anesthesiol. 1997;9:1116.[Medline]
[Order article via Infotrieve]
16.
Pollard V, Prough DS. Cerebral near-infrared
spectroscopy: a plea for modest expectations. Anesth Analg. 1996;83:673674.[Medline]
[Order article via Infotrieve]
17.
Hoffman WE, Charbel FT, Abood C, Ausman J. Regional
ischemia during cerebral bypass surgery. Surg
Neurol. 1997;47:455459.[Medline]
[Order article via Infotrieve]
18.
Kuroda S, Houkin K, Abe H, Hoshi Y, Tamura M.
Near-infrared monitoring of cerebral oxygenation state
during carotid endarterectomy. Surg
Neurol. 1996;5:450458.
19.
Williams IM, Picton AJ, Hardy SC, Mortimer AJ, McCollum
CN. Cerebral hypoxia detected by near infrared spectroscopy.
Anesthesia. 1994;49:762766.[Medline]
[Order article via Infotrieve]
20.
Duffy CM, Manninen PH, Chan A, Kearns CF. Comparison of
cerebral oximeter and evoked potential monitoring in carotid
endarterectomy. Can J Anesth. 1997;44:10771081.[Medline]
[Order article via Infotrieve]
21.
Pollard V, Prough DS, DeMelo AE, Deyo DJ, Uchida T,
Stoddart HF. Validation in volunteers of a near-infrared spectroscope
for monitoring brain oxygenation in vivo. Anesth
Analg. 1996;82:269277.[Abstract]
22.
Williams IM, Mortimer AJ, Mc Collum CN. Recent
developments in cerebral monitoring near-infrared light spectroscopy:
an overview. Eur J Vasc Endovasc Surg. 1996;12:263271.[Medline]
[Order article via Infotrieve]
23.
Colier WNJM, van Haaren NJCW, Oeseburg B. A comparative
study of two year infrared spectrophotometers for the assessment of
cerebral hemodynamics. Acta Anesthesiol
Scand. 1995;39(suppl 107):101105.
24.
Olsen KS, Svendsen LB, Larsen FS. Validation of
transcranial near-infrared spectroscopy for evaluation of
cerebral blood flow autoregulation. J Neurosurg
Anesthesiol. 1996;8:280285.[Medline]
[Order article via Infotrieve]
25.
Grubhofer G, Lassnigg A, Manlik F, Marx E, Trubel W,
Hiesmayr M. The contribution of extracranial blood
oxygenation on near-infrared spectroscopy during
carotid thrombendarterectomy.
Anaesthesia. 1997;52:116120.[Medline]
[Order article via Infotrieve]
26.
Schwarz G, Litscher G, Kleinert R, Jobstmann R.
Cerebral oximetry in dead subjects. J Neurosurg
Anesthesiol. 1996;8:189193.[Medline]
[Order article via Infotrieve]
27.
Gomersall CD, Joynt GM, Gin T, Freebairn RC, Stewart
IET. Failure of the INVOS 3100 cerebral oximeter to detect absence of
cerebral blood flow. Crit Care Med. 1997;25:12521254.[Medline]
[Order article via Infotrieve]
28.
Misra M, Stark J, Dujovny M, Widman R, Ausman JI.
Transcranial cerebral oximetry in random normal subjects.
Neurol Res. 1998;20:137141.[Medline]
[Order article via Infotrieve]
29.
McKeating EG, Monjardo JR, Signorini DF, Souter MJ,
Andrews PJD. A comparison of the INVOS 3100 and the Critikon 2020
near-infrared spectrophotometer as monitors of cerebral
oxygenation. Anesthesia. 1997;52:136140.[Medline]
[Order article via Infotrieve]
30.
Pollard V, Prough DS, DeMelo AE, Deyo DJ, Uchida T,
Widman R. The influence of carbon dioxide and body position on
near-infrared spectroscopic assessment of cerebral hemoglobin oxygen
saturation. Anesth Analg. 1996;82:278287.[Abstract]
31.
Lam JMK, Smilewski P, Al-Rawi P, Griffiths P, Pickard
JD, Kirckpatrick PJ. Internal and external carotid contributions
to near-infrared spectroscopy during carotid
endarterectomy. Stroke. 1995;28:906911.
32.
Kurth CD, Uher B. Cerebral hemoglobin and optical
pathlength influence near-infrared spectroscopy measurement of cerebral
oxygen saturation. Anesth Analg. 1997;84:12971305.[Abstract]
33.
Brown R, Wright G, Royston D. A comparison of two
systems assessing cerebral venous oxyhemoglobin saturation during
cardiopulmonary bypass in humans.
Anesthesia. 1993;48:697700.[Medline]
[Order article via Infotrieve]
34.
Harris DNF, Bailey SM. Near-infrared spectroscopy in
adults: does the INVOS 3100 really measure
intracerebral oxygenation?
Anesthesia. 1993;48:694696.[Medline]
[Order article via Infotrieve]
35.
Okada E, Firbank M, Delpy DT. The effect of overlying
tissue on the spatial sensitivity of near-infrared spectroscopy.
Phys Med Biol. 1995;40:20931208.[Medline]
[Order article via Infotrieve]
36.
Lewis SB, Myburgh JA, Thornton EL, Reilly PL. Cerebral
oxygenation monitoring by near-infrared spectroscopy.
Crit Care Med. 1996;24:13341338.[Medline]
[Order article via Infotrieve]
37.
Kirckpatrick PJ, Smilewski P, Al-Rawi P, Czosnyka M.
Resolving extra- and intracranial signal changes during adult near
infrared spectroscopy. Neurol Res. 1998;20(suppl
1):S19S22.
38.
Dujovny M, Slavin KV, Cui W, Lewis G, Ausman JI.
Somanetics INVOS 3100 cerebral oximeter. Neurosurgery. 1994;34:935936.
39.
Newman MF, Lowry E, Croughwell ND, White W, Kirchner J,
Blumenthal J. Near-infrared spectroscopy (INVOS 3100-A) and
cognitive outcome after cardiac surgery. Anesth Analg. 1997;84:S111. Abstract.
© 1998 American Heart Association, Inc.
Original Contributions
Comparison of Near-Infrared Spectroscopy and Somatosensory Evoked Potentials for the Detection of Cerebral Ischemia During Carotid Endarterectomy
![]()
Abstract
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
Background and PurposeWe sought
to assess the clinical value of regional cerebral saturation
(rSO2) obtained by means of the cerebral
oximeter INVOS 3100A (Somanetics) in comparison to monitoring of
somatosensory evoked potentials (SEP) for the reliable detection of
severe cerebral ischemia requiring shunt placement in the
individual patient undergoing carotid surgery under general
anesthesia.
Key Words: carotid stenosis cerebral ischemia evoked potentials, somatosensory intraoperative monitoring oximetry surgery
![]()
Introduction
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
The efficiency of surgical therapy for prevention of
stroke in patients with >70% carotid stenosis has recently
been clarified.1 The inherent risk of surgery is
perioperative stroke. A major cause of cerebrovascular
accidents is hypoperfusion during cross-clamping of the internal
carotid artery (ICA).2 3 4 5 The prompt and reliable
recognition of insufficient collateralization is crucial for a good
neurological outcome of patients. General use of an intraluminal shunt
bears the risk of embolization and undetected shunt
malfunction.4 Therefore, proper neuromonitoring
needs to identify patients who will benefit from shunt placement not
only with a high sensitivity but with a high specificity as well.
![]()
Subjects and Methods
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
After approval by the local ethics committee of the medical
faculty of the University of Erlangen-Nuremberg and after we obtained
informed and written consent, 317 patients (215 men, 102 women) aged 42
to 89 years were included. Preoperative neurological classification and
angiographic findings are summarized in Table 1
.
View this table:
[in a new window]
Table 1. Preoperative Neurological Status and Angiographic
Findings (n=317)
. Evoked
potentials were recorded above the postcentral region of the side
that was operated on and above the cervical spine for artifact control.
The peak-to-peak amplitudes of the cervical potential N14-P18 and the
primary cortical response N20-P25 were measured online. Because of the
results of a previous study, a critical cerebral ischemia after
cross-clamping was assumed if the peaks of the N20-P25 complex were not
readily identifiable, while the cervical control potential N14-P18
remained intact.14 Such a constellation was the
sole index for the insertion of a temporary intraluminal shunt.
View this table:
[in a new window]
Table 2. Stimulation and Recording
Parameters for SEP
3 cm away from midline to
avoid distortion from the sagittal sinus. After a stable
rSO2 reading was achieved, the
margins of the sensor were tightened with an opaque tape. The
rSO2 readings were recorded at
30-second intervals and stored for later analysis. In a study
protocol the mean value in the last 2 minutes before clamping
(rSO2-1) was noted. When the carotid
complex was exposed, the common carotid artery was cross-clamped first,
followed in rapid succession by the internal and external carotid
arteries. After cross-clamping of the ICA, the lowest value was
documented (rSO2-2) when this value
persisted for
2 minutes. The change of
rSO2
(
rSO2) in the individual patient
was calculated on the basis of these data
(
rSO2=rSO2-1-rSO2-2)
![]()
Results
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
Reconstruction of the ICA was successfully completed in all 317
patients. The most commonly performed procedures were
thromboendarterectomy with patch closure (n=208,
65.6%) and eversion endarterectomy (n=79, 24.9%).
No deaths occurred during the observation period. The range of
fluctuations for mean arterial pressure between the points
at which preclamp and postclamp rSO2
was determined was +18% to -14% for the studied population. The mean
duration of carotid cross-clamping was 35±11 minutes, with a range of
7 to 106 minutes.
rSO2) for patients with preserved
SEP and SEP loss during cross-clamping of the ICA, are summarized in
Table 3
. On average the initial absolute
values of regional cerebral oxygenation in patients
with or without later SEP loss were nearly identical; however,
considerable variability was noted. In both groups a statistically
significant decrease of rSO2
(P<0.01 by nonparametric Wilcoxon test)
after cross-clamping was found. Patients with restricted cerebral
collateralization and consecutive loss of cortical SEP after
cross-clamping had significantly lower
rSO2 values than patients with
unaffected SEP (P<0.05; nonparametric
Mann-Whitney U-test). The difference of the calculated change of
rSO2 in both groups of patients was
highly significant (P<0.001; nonparametric
Mann-Whitney U test). However, the magnitude of change again
showed a high variability (Figure 1
).
View this table:
[in a new window]
Table 3. Comparison of rSO2 Before
(rSO2-1) and After Carotid Cross-clamping
(rSO2-2) and the Calculated Decrease of
rSO2
(
rSO2=rSO2-1-rSO2-2)
in Patients With and Without SEP Loss During Cross-clamping of the ICA

View larger version (50K):
[in a new window]
Figure 1. Decrease of rSO2
(
rSO2) after cross-clamping of the ICA in
patients with and without cortical SEP loss. Numbers of patients in
each category are shown on top of the bars.
indicate, no critical threshold value
of
rSO2 could be defined that
could identify patients with SEP loss who would benefit from shunt
placement.
View this table:
[in a new window]
Table 4. Results of Validating Decrease of
rSO2 (
rSO2) Against
SEP Loss During Carotid Cross-clamping
![]()
Discussion
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
Reconstructive surgery at the carotid bifurcation is particularly
suitable to evaluate NIRS as a new form of
neuromonitoring.16 In addition to the fact that
cross-clamping of the ICA offers a well-defined period in which
cerebral damage due to hypoperfusion is most likely to occur, the
results of cerebral oximetry can be compared with other
simultaneously employed monitoring methods and the
neurological outcome of the patient immediately after surgery. However,
previous studies failed to demonstrate the clinical usefulness of the
cerebral oximeter INVOS 3100A in carotid surgery. One reason was the
use of reference methods, such as jugular-venous
oximetry,10 that are well recognized as
unreliable for detection of focal
ischemia.17 Furthermore, because of the
limited number of patients studied, comparison of the NIRS results with
individual neurological outcome did not provide conclusive evidence for
the usefulness of this device.18 19 Continuous
monitoring of the patient under regional anesthesia is
accepted as a sensitive monitor of cerebral function and can reveal
clinically significant cerebral
ischemia.4 Additionally, the effect of an
intervention such as shunt placement can be readily assessed. However,
in a study by Samra et al,9 none of the 38
patients in their series who underwent carotid surgery under regional
anesthesia developed a new neurological deficit during
carotid cross-clamping. Thus, no information about
rSO2 values with regard to critical
cerebral ischemia could be obtained.
, a dramatic fall of
rSO2 occurred immediately after
cross-clamping of the ICA in a patient in whom an SEP loss was
documented. In addition, rSO2 showed
a prompt recovery after shunt insertion and a hyperperfusion phenomenon
after definite declamping. The fall of
rSO2 occurred much earlier than the
loss of the cortical SEP because reduction of cerebral perfusion leads
to predominantly venous desaturation, and concomitant fall of
rSO2, before cerebral dysfunction
occurs. However, the clinical relevance of an early detection of
impending cerebral ischemia before cerebral dysfunction
remains unclear, since no patient in our series developed sustained
neurological deficits when shunt placement was performed after the
complete loss of cortical SEP. A possible relationship between changes
in cerebral oxygenation and more subtle adverse
neurological outcome, such as cognitive deterioration, needs to be
addressed in further studies.39

View larger version (27K):
[in a new window]
Figure 2. Course of cortical SEP and
rSO2 in a 67-year-old female patient admitted
for left carotid endarterectomy. She had a history
of completed stroke 2 years ago with no residuals. Preoperative
angiography revealed a 90% stenosis of the left side and a
unilaterally occluded vertebral artery. After cross-clamping of the
ICA, a rapid decline of rSO2 occurred, followed
by a disappearance of cortical waveform 3 minutes later. Immediate
recovery of rSO2 was found after shunt
placement. The cortical SEP recovered more gradually. Drop of
rSO2 and SEP loss occurred after shunt removal,
which was restored by carotid declamping. No neurological deficit was
found at emergence from anesthesia.
![]()
References
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
1.
Biller J, Feinberg WM, Castaldo JE, Whittemore AD,
Harbaugh JE, Dempsey RJ, Caplan LR, Kresowik TF, Matahar DB, Toole JF,
Easton JD, Adams HP, Brass LM, Hobson RW, Brott TG, Sternau L.
Guidelines for carotid endarterectomy: a statement
for healthcare professionals from a special writing group of the Stroke
Council, American Heart Association. Stroke. 1998;29:554562.
This article has been cited by other articles:
![]() |
S. Matsumoto, I. Nakahara, T. Higashi, Y. Iwamuro, Y. Watanabe, K. Takahashi, M. Ando, M. Takezawa, and J. I. Kira Near-infrared spectroscopy in carotid artery stenting predicts cerebral hyperperfusion syndrome Neurology, April 28, 2009; 72(17): 1512 - 1518. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Hemmerling, M. C. Bluteau, R. Kazan, and D. Bracco Significant decrease of cerebral oxygen saturation during single-lung ventilation measured using absolute oximetry Br. J. Anaesth., December 1, 2008; 101(6): 870 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Stoneham, O. Lodi, T. C. D. de Beer, and J. W. Sear Increased Oxygen Administration Improves Cerebral Oxygenation in Patients Undergoing Awake Carotid Surgery Anesth. Analg., November 1, 2008; 107(5): 1670 - 1675. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Urbanski, A. Lenos, J. C. Blume, V. Ziegler, B. Griewing, R. Schmitt, A. Diegeler, and M. Dinkel Does anatomical completeness of the circle of Willis correlate with sufficient cross-perfusion during unilateral cerebral perfusion? Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 402 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Fischer Recent Advances in Application of Cerebral Oximetry in Adult Cardiovascular Surgery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2008; 12(1): 60 - 69. [Abstract] [PDF] |
||||
![]() |
P. G. Al-Rawi and P. J. Kirkpatrick Tissue Oxygen Index: Thresholds for Cerebral Ischemia Using Near-Infrared Spectroscopy Stroke, November 1, 2006; 37(11): 2720 - 2725. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Orihashi, T. Sueda, K. Okada, and K. Imai Near-infrared spectroscopy for monitoring cerebral ischemia during selective cerebral perfusion Eur. J. Cardiothorac. Surg., November 1, 2004; 26(5): 907 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Orihashi, Y. Matsuura, T. Sueda, M. Watari, K. Okada, Y. Sugawara, and O. Ishii Aortic arch branches are no longer a blind zone for transesophageal echocardiography: A new eye for aortic surgeons J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 466 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J Theilen, M. Ragaller, R. von Kummer, B. Pohlmann-Eden, G. Schackert, and M. D Albrecht Functional recovery despite prolonged bilateral loss of somatosensory evoked potentials: report on two patients J. Neurol. Neurosurg. Psychiatry, May 1, 2000; 68(5): 657 - 660. [Abstract] [Full Text] |
||||
![]() |
E. M. Nemoto No Absolutes in Neuromonitoring for Carotid Endarterectomy Stroke, April 1, 1999; 30(4): 895 - 895. [Full Text] [PDF] |
||||
![]() |
H. Chant, G. Riding, A. Picton, C.N. McCollum, U. Beese, H. Langer, M. Dinkel, and W. Lang Comparison of Near-Infrared Spectroscopy and Somatosensory Evoked Potentials for the Detection of Cerebral Ischemia During Carotid Endarterectomy • Response Stroke, April 1, 1999; 30 (4): 895 - 897. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |